Chan Kin Foong Insider Trades

Insider Trading History

Track insider trading activity for Chan Kin Foong. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
EVP Of R&d
Holding Value $26.4k 77,100 shares
Last Trade
Jun 12, 2019 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$64.8k 77,100 shares
$0.84
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
EVP Of R&d
Holding Value $308k 900,000 shares
Last Trade
Dec 20, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$3.4M 1,314,000 shares
$2.58
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
EVP Of R&d
Holding Value $149k 435,000 shares
Last Trade
Apr 18, 2017 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$8M 435,000 shares
$18.40
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
EVP Of R&d
Holding Value $51.4k 150,000 shares
Last Trade
Dec 08, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.58M 150,000 shares
$10.50
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
EVP Of R&d
Holding Value $77.1k 225,000 shares
Last Trade
Jul 21, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$2.64M 170,000 shares
$15.55
$0.34
Timber Pharmaceuticals
Timber Pharmaceuticals TMBR
EVP Of R&d
Holding Value $18.8k 55,000 shares
Last Trade
Jul 01, 2016 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$894k 55,000 shares
$16.25
$0.34

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up